Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Review Article: Symptomatic Non-Acid Reflux - The New Frontier in Gastro-Oesophageal Reflux Disease
Alimentary Pharmacology and Therapeutics, 33(S1):29-35
Lectura recomendada:
Review Article: Indentifying the Causes of Reflux Events and Symptoms - New Approaches
Alimentary Pharmacology and Therapeutics, 33(S1):36-42
Lectura recomendada:
Review Article: Reflux and Asthma - Mechanisms of Interaction and Asthma Outcomes
Alimentary Pharmacology and Therapeutics, 33(S1):43-47
Lectura recomendada:
Review Article: Laryngopharyngeal Reflux - The Ear, Nose and Throat Patient
Alimentary Pharmacology and Therapeutics, 33(S1):53-57
Lectura recomendada:
Bile Acids Cause Relaxation of the Lower Esophageal Sphincter Through G-Protein-Coupled Bile Acid Receptors
Tzu Chi Medical Journal, 25(2):90-93
Lectura recomendada:
Cost and Health Consequences of Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid
Alimentary Pharmacology and Therapeutics, 38(7):794-803
Lectura recomendada:
The Outcome of Patients With Oesophageal Eosinophilic Infiltration After an Eight-Week Trial of a Proton Pump Inhibitor
Alimentary Pharmacology and Therapeutics, 38(10):1312-1319
Lectura recomendada:
Long-Term Follow Up in Patients With Gastroesophageal Reflux Disease With Specific Emphasis on Reflux Symptoms, Use of Anti-Reflux Medication and Anti-Reflux Surgery Outcome: A Retrospective Study
Scandinavian Journal of Gastroenterology, 48(11):1242-1248
Lectura recomendada:
Central Adiposity is Associated With Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: A Systematic Review and Meta Analysis
Clinical Gastroenterology and Hepatology, 11(11):1399-1412
¿Cuál de estas variables se relaciona con mayor riesgo de progresión al adenocarcinoma en pacientes con esófago de Barrett?
Introducción:
El adenocarcinoma esofágico es el cáncer cuya incidencia crece en forma más acelerada en Occidente. La tasa de supervivencia es inferior al 20% en un período de 5 años. Se ha definido al esófago de Barrett como una afección preneoplásica que se caracteriza por metaplasia intestinal (transformación del epitelio escamoso en epitelio columnar que incluye células caliciformes).
Lectura recomendada:
Association Between Length of Barrett's Esophagus and Risk of High-Grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia
Clinical Gastroenterology and Hepatology, 11(11):1430-1436